154 related articles for article (PubMed ID: 12398841)
61. Typical facioscapulohumeral dystrophy phenotype in patients without FSHD 4q35 deletion.
Krasnianski M; Neudecker S; Eger K; Jakubiczka S; Zierz S
J Neurol; 2003 Sep; 250(9):1084-7. PubMed ID: 14504970
[TBL] [Abstract][Full Text] [Related]
62. Correlation between muscle involvement, phenotype and D4Z4 fragment size in facioscapulohumeral muscular dystrophy.
Wang CH; Leung M; Liang WC; Hsieh TJ; Chen TH; Jong YJ
Neuromuscul Disord; 2012 Apr; 22(4):331-8. PubMed ID: 22153988
[TBL] [Abstract][Full Text] [Related]
63. Clinical and histopathological heterogeneity in patients with 4q35 facioscapulohumeral muscular dystrophy (FSHD).
Wood-Allum C; Brennan P; Hewitt M; Lowe J; Tyfield L; Wills A
Neuropathol Appl Neurobiol; 2004 Apr; 30(2):188-91. PubMed ID: 15043716
[No Abstract] [Full Text] [Related]
64. [Clinical and genetic characteristics of facioscapulohumeral muscular dystrophy Landuzi-Dezherina type 1].
Dadali EL; Sharkova IV; Zernov NV; Rudenskaya GE; Skoblov MY
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(11):122-128. PubMed ID: 29265097
[TBL] [Abstract][Full Text] [Related]
65. [Genetic investigations in facioscapulohumeral muscular dystrophy: a preliminary report].
Dorobek M; Kabzińska D; Ryniewicz B; Fidziańska-Dolot A; Hausmanowa-Petrusewicz I
Neurol Neurochir Pol; 2004; 38(2):83-8. PubMed ID: 15307599
[TBL] [Abstract][Full Text] [Related]
66. The magnetic resonance imaging spectrum of facioscapulohumeral muscular dystrophy.
Friedman SD; Poliachik SL; Carter GT; Budech CB; Bird TD; Shaw DW
Muscle Nerve; 2012 Apr; 45(4):500-6. PubMed ID: 22431082
[TBL] [Abstract][Full Text] [Related]
67. Complete allele information in the diagnosis of facioscapulohumeral muscular dystrophy by triple DNA analysis.
Lemmers RJL ; de Kievit P; van Geel M; van der Wielen MJ; Bakker E; Padberg GW; Frants RR; van der Maarel SM
Ann Neurol; 2001 Dec; 50(6):816-9. PubMed ID: 11761483
[TBL] [Abstract][Full Text] [Related]
68. Significance of Beevor's sign in facioscapulohumeral dystrophy and other neuromuscular diseases.
Shahrizaila N; Wills AJ
J Neurol Neurosurg Psychiatry; 2005 Jun; 76(6):869-70. PubMed ID: 15897515
[TBL] [Abstract][Full Text] [Related]
69. Distal muscular dystrophy of the Miyoshi type.
Yildiz H; Emre U; Coskun O; Ergün U; Atasoy HT; Inan LE
Clin Neuropathol; 2003; 22(4):204-8. PubMed ID: 12908758
[TBL] [Abstract][Full Text] [Related]
70. Equal proportions of affected cells in muscle and blood of a mosaic carrier of facioscapulohumeral muscular dystrophy.
Tonini MM; Lemmers RJ; Pavanello RC; Cerqueira AM; Frants RR; van der Maarel SM; Zatz M
Hum Genet; 2006 Mar; 119(1-2):23-8. PubMed ID: 16341710
[TBL] [Abstract][Full Text] [Related]
71. Rimmed vacuoles in facioscapulohumeral muscular dystrophy: a unique ultrastructural feature.
Neudecker S; Krasnianski M; Bahn E; Zierz S
Acta Neuropathol; 2004 Sep; 108(3):257-9. PubMed ID: 15221332
[TBL] [Abstract][Full Text] [Related]
72. An unusual family with Leber's hereditary optic neuropathy and facioscapulohumeral muscular dystrophy.
Chuenkongkaew WL; Lertrit P; Limwongse C; Nilanont Y; Boonyapisit K; Sangruchi T; Chirapapaisan N; Suphavilai R
Eur J Neurol; 2005 May; 12(5):388-91. PubMed ID: 15804271
[TBL] [Abstract][Full Text] [Related]
73. Skeletal muscle imaging in facioscapulohumeral muscular dystrophy, pattern and asymmetry of individual muscle involvement.
Rijken NH; van der Kooi EL; Hendriks JC; van Asseldonk RJ; Padberg GW; Geurts AC; van Engelen BG
Neuromuscul Disord; 2014 Dec; 24(12):1087-96. PubMed ID: 25176503
[TBL] [Abstract][Full Text] [Related]
74. Acupuncture Improves the Facial Muscular Function in a Case of Facioscapulohumeral Muscular Dystrophy.
Liu Y; Xiao F; Liang X
J Acupunct Meridian Stud; 2019 Apr; 12(2):73-76. PubMed ID: 30508665
[TBL] [Abstract][Full Text] [Related]
75. Cognitive impairment and cerebellar atrophy in typical onset 4Q35 fascioscapulohumeral dystrophy.
Zouvelou V; Rentzos M; Zalonis I; Filippopolitis K; Manta P; Evdokimidis I
Muscle Nerve; 2008 Nov; 38(5):1523-1524. PubMed ID: 18816620
[No Abstract] [Full Text] [Related]
76. Permanent muscle weakness in McArdle disease.
Nadaj-Pakleza AA; Vincitorio CM; Laforêt P; Eymard B; Dion E; Teijeira S; Vietez I; Jeanpierre M; Navarro C; Stojkovic T
Muscle Nerve; 2009 Sep; 40(3):350-7. PubMed ID: 19670320
[TBL] [Abstract][Full Text] [Related]
77. [Gene diagnosis of facioscapulohumeral muscular dystrophy].
Zhang JL; Shen DG; Zhou PK; Liu JW; Jia N; Liu H; Wang HB; Yang SX; Frants RR
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Jun; 20(3):232-4. PubMed ID: 12778451
[TBL] [Abstract][Full Text] [Related]
78. Germline mosaicism in 4q35 facioscapulohumeral muscular dystrophy (FSHD1A) occurring predominantly in oogenesis.
Köhler J; Rupilius B; Otto M; Bathke K; Koch MC
Hum Genet; 1996 Oct; 98(4):485-90. PubMed ID: 8792827
[TBL] [Abstract][Full Text] [Related]
79. Ultrasound pattern of anterolateral leg muscles in facioscapulohumeral muscular dystrophy.
Veltsista D; Chroni E
Acta Neurol Scand; 2021 Aug; 144(2):216-220. PubMed ID: 33844852
[TBL] [Abstract][Full Text] [Related]
80. Creatine phosphokinase in facioscapulohumeral muscular dystrophy.
Hughes BP
Br Med J; 1971 Aug; 3(5772):464-5. PubMed ID: 5567771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
